News

Fierce Pharma25m
Fierce Pharma Asia—Vor-RemeGen, Otsuka-Harbour autoimmune deals; Datroway's lung cancer nod
A potential $4 billion licensing deal with Vor Bio triggered a slide in RemeGen's stock price. Otsuka obtained a BCMAXCD3 ...
Fierce Pharma21h
Incyte waves goodbye to longtime CEO Hervé Hoppenot as new appointment raises M&A hopes
After over a decade spent building Incyte up into a competitive commercial drugmaker, the company’s longtime CEO Hervé ...
Fierce Pharma21h
CDC immunization advisory panel endorses Merck's new RSV shot, but not without dissent
The CDC’s Advisory Committee on Immunization Practices (ACIP) has blessed Merck’s new respiratory syncytial virus (RSV) shot ...
Fierce Pharma22h
Vor Bio's surprise $4B revival deal for RemeGen's autoimmune drug triggers divergent stock reactions
For $45 million upfront, Vor Bio is gaining ex-China rights to RemeGen’s telitacicept, a first-in-class recombinant ...
Fierce Pharma16h
With thimerosal vote, RFK Jr.'s ACIP shows willingness to take on vaccine convention
Robert F. Kennedy Jr.’s revamped Advisory Committee on Immunization Practices has struck its first blow against established ...
Fierce Pharma22h
Emergent lands $62.4M upgrade to botulism antitoxin supply pact with US
A little less than a year after topping up its medical countermeasure contracts with Emergent BioSolutions, the federal ...
Fierce Pharma17h
GSK, Gilead, Novo Nordisk join other Big Pharmas in honoring 2025 LGBTQ+ Pride month
A Fierce Pharma Marketing review of the LinkedIn and Instagram pages of the 20 largest pharmas found that, as of Thursday, ...
Fierce Pharma22h
Abbott in partnership focused on producing pharmaceuticals in Abu Dhabi
U.S. multinational company Abbott entered a partnership with Abu Dhabi's Department of Health to manufacture medicines in the ...